|
Volumn 31, Issue 4, 2004, Pages 539-547
|
A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HUMAN;
LEUKOPENIA;
MIDDLE AGED;
MULTICENTER STUDY;
NAUSEA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
TUMOR RECURRENCE;
VOMITING;
ADULT;
AGED;
ANOREXIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
BREAST NEOPLASMS;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
LEUKOPENIA;
MIDDLE AGED;
NAUSEA;
NEOPLASM RECURRENCE, LOCAL;
NEUTROPENIA;
OXONIC ACID;
PYRIDINES;
TEGAFUR;
VOMITING, ANTICIPATORY;
|
EID: 2342547782
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|